Pathophysiology of Q waves in II, III, avF in systemic lupus erythematosus. Evaluation using cardiovascular magnetic resonance imaging

Lupus

Volumn 21, Issue 8, 2012, Pages 821-829

  Mavrogeni, S ^a   Bratis, K ^a   Kolovou, G ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

cardiovascular magnetic resonance; coronary artery disease; myocarditis; Systemic lupus erythematosus

Indexed keywords

GADOLINIUM;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR SYMPTOM; CLINICAL ARTICLE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DIFFUSION WEIGHTED IMAGING; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; EARLY GADOLINIUM ENHANCEMENT; ECG ABNORMALITY; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMAGE ENHANCEMENT; IMAGE QUALITY; LATE GADOLINIUM ENHANCEMENT; MYOCARDITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; Q WAVE; REMISSION; SYSTEMIC LUPUS ERYTHEMATOSUS; T2 WEIGHTED IMAGE;

ADULT; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GADOLINIUM DTPA; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDITIS; STROKE VOLUME; TIME FACTORS;

EID: 84861825511     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312437437     Document Type: Article

References (34)

1. Tincani A, Rebaioli CB, Taglietti M, Shoenfeld Y. Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology. 2006 ; 45 (Suppl. 4). iv8 - iv13
2. Doria A, Iaccarino L, Sarzi-Puttini P, et al. Cardiovascular involvement in systemic lupus erythematosus. Lupus. 2005 ; 14: 683-686
3. Ishimori ML, Martin R, Berman DS, et al. Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. JACC Cardiovasc Imaging. 2011 ; 4: 27-33
4. O'Neill SG, Woldman S, Bailliard F, et al. Cardiac magnetic resonance imaging in patients with systemic lupus erythematosus. Ann Rheum Dis. 2009 ; 68: 1478-1481
5. Abdel-Aty H, Siegle N, Natusch A, et al. Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach. Lupus. 2008 ; 17: 561-567
6. Mavrogeni S, Spargias K, Markussis V, et al. Myocardial inflammation in autoimmune diseases: investigation by cardiovascular magnetic resonance and endomyocardial biopsy. Inflamm Allergy Drug Targets. 2009 ; 8: 390-397
7. Asch FM, Shah S, Rattin C, Swaminathan S, Fuisz A, Lindsay J. Lack of sensitivity of the electrocardiogram for detection of old myocardial infarction: a cardiac magnetic resonance imaging study. Am Heart J. 2006 ; 152: 742-748
8. Ukena C, Mahfoud F, Kindermann I, Kandolf R, Kindermann M, Böhm M. Prognostic electrocardiographic parameters in patients with suspected myocarditis. Eur J Heart Fail. 2011 ; 13: 398-405
9. Stone PH, Thompson B, Anderson HV, et al. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: the TIMI III registry. JAMA. 1996 ; 275: 1104-1112
10. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
11. Vitali C, Bencivelli W, Isenberg DA, et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol. 1992 ; 10: 541-547
12. Whelton PK. Epidemiology of hypertension. Lancet. 1994 ; 344: 101-106
13. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
14. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance: National Diabetes Data Group. Diabetes 1979; 28: 1039-1057.
15. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993; 269: 3015-3023.
16. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 ; 289: 2560-2572
17. Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S. The electrocardiogram in population studies: a classification system. Circulation. 1960 ; 21: 1160-1175
18. Friedrich MG, Strohm O, Schulz-Menger J, et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation. 1998 ; 97: 1802-1809
19. Friedrich M, Sechtem U, Schulz-Menger J, et al. International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis: Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009 ; 53: 1475-1487
20. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 2001 ; 357: 21-28
21. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003 ; 361: 374-379
22. Bondarenko O, Beek AM, Nijveldt R, et al. Functional outcome after revascularization in patients with chronic ischemic heart disease: a quantitative late gadolinium enhancement CMR study evaluating transmural scar extent, wall thickness and periprocedural necrosis. J Cardiovasc Magn Reson. 2007 ; 9: 815-821
23. Cagán S, Kuchárová L. (Evaluation of the Q wave in leads II, III, and aVF. Deviation of the electrical axis of the heart, ischemic heart disease). Vnitr Lek. 1989 ; 35: 743-751
24. MacKenzie R. The challenge of inferior Q waves. J Insur Med. 2007 ; 39: 126-134
25. Mavrogeni S, Bratis C, Iakovou I, Kolovou G. Systemic lupus erythematosus. Two sides of the same coin evaluated by cardiovascular magnetic resonance imaging. Lupus 29 July 2011; 20: 1338-1339.
26. Panchal L, Divate S, Vaideeswar P, Pandit SP. Cardiovascular involvement in systemic lupus erythematosus: an autopsy study of 27 patients in India. J Postgrad Med. 2006 ; 52: 5-10
27. Wijetunga M, Rockson S. Myocarditis in systemic lupus erythematosus. Am J Med. 2002 ; 113: 419-423
28. Rovai D, Di Bella G, Rossi G, et al. Q-wave prediction of myocardial infarct location, size and transmural extent at magnetic resonance imaging. Coron Artery Dis. 2007 ; 18: 381-389
29. Sztajzel J, Urban P. Early and late Q wave regression in the setting of acute myocardial infarction. Heart. 2000 ; 83: 708-710
30. Bax JJ, Bonow RO, Tschope D, Inzucchi SE, Barrett E. The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes. J Am Coll Cardiol. 2006 ; 48: 754-760
31. DeLuca AJ, Kaplan S, Aronow WS, et al. Comparison of prevalence of unrecognized myocardial infarction and of silent myocardial ischemia detected by a treadmill exercise sestamibi stress test in patients with versus without diabetes mellitus. Am J Cardiol. 2006 ; 98: 1045-1046
32. Ricciardi MJ, Wu E, Davidson CJ, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation. 2001 ; 103: 2780-2783
33. Gutberlet M, Spors B, Thoma T, et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology. 2008 ; 246: 401-409
34. Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J. 1985 ; 110: 1257-1265